Table 5. Predicted Affinities and Cooperativities for VU0155094 across the Group III mGlus Using Calcium Assays with Chimeric G Proteins Reveals Distinct Receptor–PAM Interactionsa.
mGlu4 |
mGlu7 |
mGlu8 |
|||||||
---|---|---|---|---|---|---|---|---|---|
Glu | L-AP4 | LSP4-2022 | Glu | L-AP4 | LSP4-2022 | Glu | L-AP4 | LSP4-2022 | |
pKB | 4.88 ± 0.03 | 4.88 ± 0.05d | 4.97 ± 0.10 | 4.77 ± 0.18c | 5.38 ± 0.22cd | 5.10 ± 0.17e | 5.07 ± 0.37 | 4.83 ± 0.07d | 4.85 ± 0.08e |
KB (μM) | 13.3 | 13.2 | 10.6 | 17 | 4.2 | 8.0 | 8.6 | 14.7 | 14.0 |
log τB | n.a | n.a | n.a | –0.17 ± 0.03 | –0.09 ± 0.04 | –0.22 ± 0.06 | –0.12 ± 0.03 | –0.14 ± 0.04 | –0.10 ± 0.06 |
τB | n.a | n.a | n.a | 0.81 | 1.16 | 0.61 | 0.75 | 0.73 | 0.80 |
log β | 0.16 ± 0.08fh | 0.67 ± 0.27fi | 0.33 ± 0.07j | 0.68 ± 0.12gh | 0.07 ± 0.03gi | –0.10 ± 0.10gj | 0.08 ± 0.02h | 0.05 ± 0.03i | 0.05 ± 0.06j |
β | 1.4 | 4.7 | 2.1 | 4.8 | 1.2 | 0.8 | 1.2 | 1.1 | 1.1 |
log α | 0.28 ± 0.07 | –0.15 ± 0.30k | 0.17 ± 0.13l | 0.58 ± 0.13 | 0.39 ± 0.21 | 0.82 ± 0.26l | 0.61 ± 0.39 | 0.92 ± 0.08k | 0.93 ± 0.06l |
α | 1.9 | 0.71 | 1.5 | 3.8 | 2.4 | 6.6 | 4.1 | 8.3 | 8.6 |
n | 6.2 ± 1.8 | 2.0 ± 0.2 | 2.2 ± 0.03 | 2.3 ± 0.4 | 6.7 ± 3.1 | 2.9 ± 1.2 | 4.6 ± 2.5 | 2.9 ± 0.4 | 3.0 ± 0.3 |
basal | 6.9 ± 1.8 | 7.1 ± 0.7 | 7.6 ± 0.6 | 0.4 ± 2.3 | 3.3 ± 2.4 | 3.8 ± 0.8 | 3.3 ± 0.4 | 2.4 ± 0.3 | 2.3 ± 0.5 |
Emb | 195.7 | 195.7 | 195.7 | 377.2 | 377.2 | 377.2 | 102.3 | 102.3 | 102.3 |
Data were fitted from curves shown in Figure S4 (Supporting Information) using eq 2. The α value was shared between data sets, and the Em was constrained to the maximal level of potentiation observed for that subtype between any combination of ligands in a given experiment. For statistical analyses, pKB, log α, and log β values were compared between agonists at one receptor and then separately between receptors for a given agonist. All statistical tests were one-way ANOVA with a Tukey’s post-test to compare all columns. Data are comprised of three individual experiments performed in duplicate (mean ± SD values shown).
Em value constrained to the maximal level of potentiation observed for that subtype between any combination of ligands in a given experiment; the mean is reported. All p values <0.05.
pKB between mGlu7/glutamate versus mGlu7/L-AP4.
pKB between mGlu7/L-AP4 versus mGlu4/L-AP4 and mGlu8/L-AP4.
pKB between mGlu7/LSP4-2022 versus mGlu8/LSP4-022.
Log β between mGlu4/glutamate versus mGlu4/L-AP4.
Log β between mGlu7/glutamate versus mGlu7/L-AP4 and mGlu7/LSP4-2022.
Log β between mGlu7/glutamate versus mGlu4/glutamate and mGlu8/glutamate.
Log β between mGlu4/L-AP4 versus mGlu7/L-AP4 and mGlu8/L-AP4.
Log β between mGlu4/LSP4-2022 versus mGlu7/LSP4-2022 and mGlu8/LSP4-2022.
Log α of mGlu4/L-AP4 versus mGlu8/L-AP4.
Log α of mGlu4/LSP4-2022 versus mGlu7/LSP4-2022 and mGlu8/LSP4-2022.